Group One Trading’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-37
| Closed | -$125 | – | 9308 |
|
|
2025
Q2 | $125 | Hold |
37
| – | – | ﹤0.01% | 7778 |
|
|
2025
Q1 | $108 | Hold |
37
| – | – | ﹤0.01% | 7404 |
|
|
2024
Q4 | $100 | Buy |
+37
| New | +$121 | ﹤0.01% | 7099 |
|
|
2024
Q1 | – | Sell |
-750
| Closed | -$5.58K | – | 8112 |
|
|
2023
Q4 | $5.58K | Hold |
750
| – | – | ﹤0.01% | 6462 |
|
|
2023
Q3 | $7.26K | Hold |
750
| – | – | ﹤0.01% | 6523 |
|
|
2023
Q2 | $7.68K | Hold |
750
| – | – | ﹤0.01% | 6525 |
|
|
2023
Q1 | $7.83K | Sell |
750
-2,574
| -77% | -$34.2K | ﹤0.01% | 6075 |
|
|
2022
Q4 | $42.5K | Buy |
3,324
+1,103
| +50% | +$16.4K | ﹤0.01% | 5119 |
|
|
2022
Q3 | $35K | Hold |
2,221
| – | – | ﹤0.01% | 5691 |
|
|
2022
Q2 | $44K | Sell |
2,221
-1
| -0% | -$25 | ﹤0.01% | 5681 |
|
|
2022
Q1 | $81K | Buy |
2,222
+299
| +16% | +$10.8K | ﹤0.01% | 5702 |
|
|
2021
Q4 | $68K | Buy |
1,923
+1,314
| +216% | +$69.2K | ﹤0.01% | 6079 |
|
|
2021
Q3 | $46K | Sell |
609
-623
| -51% | -$44.2K | ﹤0.01% | 6608 |
|
|
2021
Q2 | $108K | Buy |
+1,232
| New | +$117K | ﹤0.01% | 5877 |
|
|
2020
Q2 | – | Sell |
-4
| Closed | -$366 | – | 6267 |
|
|
2020
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 5829 |
|
|
2019
Q4 | $0 | Sell |
4
-7
| -64% | -$653 | ﹤0.01% | 5713 |
|
|
2019
Q3 | $1K | Buy |
+11
| New | +$2.38K | ﹤0.01% | 5023 |
|
|
2017
Q4 | – | Sell |
-147
| Closed | -$30.6K | – | 5298 |
|
|
2017
Q3 | $30K | Buy |
+147
| New | +$27.1K | ﹤0.01% | 3886 |
|
|
2017
Q1 | – | Sell |
-6
| Closed | -$1.77K | – | 5065 |
|
|
2016
Q4 | $2K | Sell |
6
-787
| -99% | -$293K | ﹤0.01% | 4272 |
|
|
2016
Q3 | $272K | Buy |
793
+250
| +46% | +$87.6K | ﹤0.01% | 2261 |
|
|
2016
Q2 | $177K | Buy |
+543
| New | +$195K | ﹤0.01% | 2486 |
|
Other funds holding CSCI
Group One Trading's CSCI Position: Q3 2025 in Review
Group One Trading sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2025, closing a stake of 37 shares — an estimated $125 sold.
Group One Trading first reported a position in CSCI in Q2 2016 and held it in 21 quarters. The position peaked at $272K in Q3 2016. 2 funds tracked by Wall St. Rank hold CSCI as of Q3 2025.
- Group One Trading reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
- Group One Trading sold 37 COSCIENS Biopharma Inc. Common Stock shares in Q3 2025, an estimated $125.
- Group One Trading first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2016 and held it in 21 quarters.
- Group One Trading's COSCIENS Biopharma Inc. Common Stock position peaked at $272K in Q3 2016.
- 2 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2025.
Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.